Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.74 USD | +3.54% |
|
+10.74% | -12.77% |
01:44pm | Truist Raises Price Target on Inari Medical to $60 From $47, Maintains Hold Rating | MT |
Jul. 15 | Morgan Stanley Raises Price Target on Inari Medical to $60 From $55, Keeps Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.77% | 3.19B | |
+75.67% | 12.57B | |
-22.67% | 7.43B | |
-7.22% | 5.79B | |
+8.16% | 5.09B | |
-17.37% | 4.78B | |
+16.22% | 4.2B | |
-15.15% | 4.13B | |
-1.98% | 2B | |
+26.26% | 1.94B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Truist Raises Price Target on Inari Medical to $60 From $47, Maintains Hold Rating